僅用于工業(yè)應(yīng)用或科學(xué)研究,不可用于人類或動(dòng)物的臨床診斷或治療,非藥用. Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody targeting CTLA-4 (CTLA-4). Zalifrelimab antagonizes the inhibitory checkpoints of immune cell activation regulated by CTLA-4 signaling